GLP-1 Weight Loss Medication List: A Comprehensive Guide
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications used to treat Type 2 diabetes and support weight loss. These medications mimic the action of the GLP-1 hormone, which is naturally produced in the gut. The GLP-1 hormone regulates appetite, glucose metabolism, and insulin secretion, making it an attractive target for the development of weight loss medications.
Understanding the Mechanism of Action
GLP-1 receptor agonists work by binding to the GLP-1 receptor in the pancreas, mimicking the action of the naturally occurring GLP-1 hormone. This binding action increases insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, leading to weight loss.

GLP-1 Weight Loss Medications: A List of FDA-Approved Options
Several GLP-1 weight loss medications have been approved by the FDA for the treatment of obesity and weight loss. These medications include:
- Semaglutide (Wegovy): A higher-dose version of the medication used to treat Type 2 diabetes, Wegovy has been approved for weight loss at a dose of 2.4 mg per week.
- Liraglutide (Saxenda): Another GLP-1 receptor agonist approved for weight loss, Saxenda has been shown to help individuals lose a significant amount of weight and improve glycemic control.
- Octreotide (NovoSeven): While not specifically approved for weight loss, Octreotide can be used off-label for weight loss in some cases.
- Albiglutide (Tanzeum): A GLP-1 receptor agonist that has been approved for the treatment of Type 2 diabetes, Tanzeum has also been studied for its potential use in weight loss.
- Linagliptin (Trulicity): Although not specifically approved for weight loss, Trulicity has been studied for its potential benefits in weight loss and glycemic control.
- Exenatide (Byetta): Developed for the treatment of Type 2 diabetes, Exenatide has been shown to have potential benefits for weight loss in some cases.
- Memerlutide: A longer-acting formulation of Exenatide, MEM-285 has been approved for the treatment of Type 2 diabetes and has potential benefits for weight loss.
- Tirzepatide: A dual GIP/GLP-1 receptor agonist, Tirzepatide has been approved for the treatment of Type 2 diabetes and has shown potential benefits for weight loss.
- Orlistat (Alli): While not a GLP-1 receptor agonist, Orlistat is a medication that is used for weight loss and works by reducing fat absorption.